ATE445637T1 - Synthese von peptid t-20 mit peptidfragmentzwischenprodukten - Google Patents

Synthese von peptid t-20 mit peptidfragmentzwischenprodukten

Info

Publication number
ATE445637T1
ATE445637T1 AT05823175T AT05823175T ATE445637T1 AT E445637 T1 ATE445637 T1 AT E445637T1 AT 05823175 T AT05823175 T AT 05823175T AT 05823175 T AT05823175 T AT 05823175T AT E445637 T1 ATE445637 T1 AT E445637T1
Authority
AT
Austria
Prior art keywords
peptide
synthesis
intermediate products
fragment intermediate
peptide fragment
Prior art date
Application number
AT05823175T
Other languages
English (en)
Inventor
Yeun-Kwei Han
David Johnston
Hiralal Khatri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE445637T1 publication Critical patent/ATE445637T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05823175T 2004-12-30 2005-12-22 Synthese von peptid t-20 mit peptidfragmentzwischenprodukten ATE445637T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64082204P 2004-12-30 2004-12-30
PCT/EP2005/013852 WO2006069727A2 (en) 2004-12-30 2005-12-22 Synthesis of peptide t-20 using peptide intermediate fragments

Publications (1)

Publication Number Publication Date
ATE445637T1 true ATE445637T1 (de) 2009-10-15

Family

ID=36520126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05823175T ATE445637T1 (de) 2004-12-30 2005-12-22 Synthese von peptid t-20 mit peptidfragmentzwischenprodukten

Country Status (12)

Country Link
US (1) US20070213504A1 (de)
EP (1) EP1960423B1 (de)
JP (1) JP4886701B2 (de)
KR (1) KR20070111463A (de)
CN (1) CN101133078B (de)
AT (1) ATE445637T1 (de)
CA (1) CA2593864C (de)
DE (1) DE602005017206D1 (de)
ES (1) ES2332142T3 (de)
IL (1) IL184081A (de)
MX (1) MX2007007916A (de)
WO (1) WO2006069727A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101835794A (zh) * 2007-10-27 2010-09-15 霍夫曼-拉罗奇有限公司 使用固相和溶液相组合技术的促胰岛素肽合成法
EP2222695A2 (de) * 2007-12-11 2010-09-01 F. Hoffmann-La Roche AG Synthese eines insulinotropen peptids mithilfe von feststoff- und flüssigphasenkombinationsverfahren
CN102680463B (zh) * 2012-05-17 2014-07-02 新疆天康畜牧生物技术股份有限公司 一种改进的茚三酮对固相多肽合成的检测方法
CN110372781B (zh) * 2019-07-29 2021-11-16 深圳佳肽生物科技有限公司 恩夫韦肽的制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817758A (en) * 1995-06-07 1998-10-06 Terrapin Technologies, Inc. P-nitrobenzyl side-chain protection for solid-phase synthesis
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto

Also Published As

Publication number Publication date
CN101133078A (zh) 2008-02-27
CA2593864C (en) 2013-08-06
MX2007007916A (es) 2007-08-14
IL184081A0 (en) 2007-10-31
EP1960423B1 (de) 2009-10-14
CN101133078B (zh) 2011-07-27
WO2006069727A2 (en) 2006-07-06
ES2332142T3 (es) 2010-01-27
JP4886701B2 (ja) 2012-02-29
IL184081A (en) 2010-12-30
EP1960423A2 (de) 2008-08-27
WO2006069727A3 (en) 2006-08-10
US20070213504A1 (en) 2007-09-13
CA2593864A1 (en) 2006-07-06
JP2008526697A (ja) 2008-07-24
DE602005017206D1 (de) 2009-11-26
KR20070111463A (ko) 2007-11-21

Similar Documents

Publication Publication Date Title
ATE507235T1 (de) Synthese von glucagon-ähnlichen peptiden
WO2006027705A3 (en) Synthesis of triethylenetetramines
DE602005008996D1 (de) Radiofluorierte peptide
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
EA200801735A1 (ru) Антиамилоидные иммуногенные композиции, способы и применения
AR076977A1 (es) Proteinas precursoras repetitivas autoensambladas
BRPI0718996A2 (pt) Síntese de peptídio em fase sólida com boc e fmoc.
CL2008003660A1 (es) Metodo para obtener un peptido insulinotropico tipo glp-1 mediante la union de fragmentos del mismo ya sea en solucion o en fase solida; y peptidos intermediarios aqui empleados.
EA200700717A1 (ru) Сульфонамиды
WO2006116181A3 (en) Regulatory t cell mediator proteins and uses thereof
IL184080A0 (en) Synthesis of peptide t-20 using peptide intermediate fragments
IL184081A0 (en) Synthesis using peptide intermediate fragments iii
ATE439371T1 (de) Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten
EA201291416A1 (ru) Пептиды, связывающиеся с рецептором инсулиноподобного фактора роста 1
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
EA200801294A1 (ru) Пептиды-индукторы бактериоцина
DE60326128D1 (de) Verwendung von mischungen von lipopeptiden zur bereitung von impfstoffen
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
ATE512159T1 (de) Cyclodipeptidsynthetasen und ihre verwendung zur synthese von cyclo(leu-leu)cyclodipeptid
DE60306636D1 (de) Wachstumhormonsekretionsförderer
DE602005003922D1 (de) Synthese von spongosin
WO2011068538A3 (en) General method for generating ultra-high affinity binding proteins
DE602006008751D1 (de) Synthese von proteaseinhibitorvorstufen
EA200701031A1 (ru) Молекулы, способствующие гематопоэзу
ATE496061T1 (de) Festphasenpeptidsynthese

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties